Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFRMahboob Rahman, Richard A. Preston, Jackson T. Wright et al.|Clinical Journal of the American Society of Nephrology|2012Cited by 94
Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Carol Stanford, Charles Baimbridge et al.|American Journal of Kidney Diseases|2008Cited by 84
Long‐Term Follow‐Up of Moderately Hypercholesterolemic Hypertensive Patients Following Randomization to Pravastatin vs Usual Care: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (<scp>ALLHAT</scp>‐<scp>LLT</scp>)Karen L. Margolis, Jeff D. Williamson, Barry R. Davis et al.|Journal of Clinical Hypertension|2013Cited by 27